Your browser doesn't support javascript.
loading
A randomized, double-blind, and placebo-controlled multicenter clinical trial of a novel cytotoxic T-lymphocyte antigen-4 fusion protein, Leining, in Chinese active rheumatoid arthritis patients with an inadequate response to methotrexate.
Fan, Wei; Zhao, Dong-bao; Hu, Shao-xian; Xu, Hu-ji; Zhang, Xiao; Zhang, Miu-jia; Chen, Zhi-wei; Zhang, Feng-xiao; Zhu, Ping; Li, Xin-fu; Bi, Li-Qi; Zhou, Bin; Bao, Chun-de.
Affiliation
  • Fan W; Department of Rheumatology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Middle Shandong Road, Shanghai, 200001, China.
Rheumatol Int ; 34(11): 1519-27, 2014 Nov.
Article in En | MEDLINE | ID: mdl-24671501
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Recombinant Fusion Proteins / Methotrexate / Immunoconjugates / Antirheumatic Agents / Immunosuppressive Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Rheumatol Int Year: 2014 Type: Article Affiliation country: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Arthritis, Rheumatoid / Recombinant Fusion Proteins / Methotrexate / Immunoconjugates / Antirheumatic Agents / Immunosuppressive Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Rheumatol Int Year: 2014 Type: Article Affiliation country: China